Back to STATE STREET CORP STATE STREET CORP

TBPHTBPH
Showing 8 of 10 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in THERAVANCE BIOPHARMA INC

STATE STREET CORP holds 1.3M shares of TBPH (THERAVANCE BIOPHARMA INC), worth $21.1M as of 2026-Q1. The position was increased (+17.7% shares). TBPH represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$21.1M

Current Shares

1.3M

Total Value Change

+$10.3M

Total Shares Change

+29,948

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.3M
+17.7%
$21.1M0.0%$13.96
33
2025-Q4
Increased
1.1M
+4.4%
$20.6M0.0%$18.91
30
2025-Q3
Increased
1.1M
+2.0%
$15.4M0.0%$14.43
29
2025-Q2
Decreased
1M
-2.9%
$11.4M0.0%$11.22
0
2025-Q1
Decreased
1.1M
-12.7%
$9.5M0.0%$9.23
0
2024-Q4
Increased
1.2M
+2.6%
$11.5M0.0%$9.47
29
2024-Q3
Decreased
1.2M
-6.0%
$9.6M0.0%$8.10
0
2024-Q2
Decreased
1.3M
-7.4%
$10.7M0.0%$8.48
0

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used